Charite University, Berlin, Germany: clinical-trial pipeline

Charite University, Berlin, Germany is the sponsor of 853 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 102 are not yet finished and 3 were first posted in the last 90 days. Source: Arcadium Data, data as of .

Open trials102
Phase 2/3 and 358
Countries41
New in 90 days3

Trials by phase

PhaseTrials
Not applicable646
Phase 286
Phase 441
Phase 336
Phase 2/322
Phase 1/214
Phase 16
Early phase 12

Trials by status

StatusTrials
Completed479
Unknown202
Recruiting78
Terminated47
Withdrawn or not authorised19
Not yet recruiting14
Active, not recruiting10
Suspended or halted4

Condition areas

AreaTrials
Cardiovascular131
Neurology112
Oncology96
Psychiatry and mental health79
Immunology and rheumatology68
Rare and genetic diseases59
Infectious disease and vaccines53
Musculoskeletal46
Dermatology41
Metabolic and endocrine (diabetes, obesity)41
Nephrology and urology34
Gastroenterology and liver30

Countries

CountryTrials
Germany807
Austria12
Italy11
Spain10
United Kingdom9
France8
Netherlands8
Poland7
Belgium6
Czechia6
Denmark6
Israel6
Switzerland5
Australia4
Hungary4

Latest changes

DayChangeTrial
2026-09-28New trial postedDehydroepiandrosterone (DHEA) as Augmentation of Standard Antidepressants in Treatment-re…
2026-09-10New trial postedLiver Transplantation for Non-Resectable Colorectal Liver Metastases Without Local Treatm…
2026-09-10New trial postedCIRCA-MED WP1 & WP3 - Circadian Rhythms in ICU Patients

Open trials

The 25 most recently changed open trials.

Registry idTitlePhaseStatusCountries
NCT03590171International Study for Treatment of High Risk Childhood Relapsed ALL 2010Phase 2Active, not recruitingAustria, Australia, Belgium, Czechia +13
NCT06475495Comparison of B-cell Depletion by Rituximab and Anti-CD 19 CAR-T Therapy in Patients With Rheumatoid ArthritisPhase 1/2Active, not recruitingGermany
NCT07843927Dehydroepiandrosterone (DHEA) as Augmentation of Standard Antidepressants in Treatment-resistant Depression.Phase 3RecruitingGermany
NCT07004413Continuous or Intermittent Cetuximab Plus FOLFIRI as First-line Treatment in RAS/BRAF Wild-type mCRC PatientsPhase 3Not yet recruitingGermany
NCT07476729International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)Phase 3Not yet recruitingAustria, Belgium, Switzerland, Czechia +16
NCT05192655Artificial Intelligence in Functional Imaging for Individualized Treatment of Head and Neck Squamous Cell Car…Not applicableRecruitingGermany
NCT06140875Amplitude Modulated Radiofrequency Electromagnetic Field Treatment Combined With Radiochemotherapy and Mainte…Not applicableRecruitingGermany
NCT05991102Amplitude Modulated Radiofrequency Electromagnetic Field Treatment Combined With TAS-102 (Lonsurf) and Bevaci…Not applicableRecruitingGermany
NCT07811453Liver Transplantation for Non-Resectable Colorectal Liver Metastases Without Local Treatment OptionsNot applicableNot yet recruitingGermany
NCT07711535Development of Context-Adapted Quality Indicators for Early Sepsis Care in Sub-Saharan Africa - A Modified De…Not applicableRecruitingGhana
NCT06874296Assessing Declined Liver Grafts With Normothermic Machine Perfusion to Reduce Transplant Waiting TimeNot applicableRecruitingGermany
NCT07680452Clinical Study on High-fiber Diet and Short-term Fasting in Melanoma Under Immunotherapy With Checkpoint Inhi…Not applicableRecruitingGermany
NCT07529197Observational Study on Immunoadsorption (IA) in Patients With Autoantibody-Positive Post-Infectious ME/CFSNot applicableRecruitingGermany
NCT07414251Evaluation of Preoperative Preparation in Children Undergoing Cardiac Surgery or CatheterizationNot applicableRecruitingGermany
NCT06658379Prospective Validation Study of the CD8+TEMRA Cells As a Prognostic Biomarker of Healing Outcome After Fractu…Not applicableRecruitingGermany
NCT05099315Microbiome in Atopic Dermatitis Under Systemic TherapyNot applicableRecruitingGermany
NCT06256952Effect of Social Isolation on the Role of Pavlovian Mechanisms for Control Over Alcohol UseNot applicableNot yet recruitingGermany
NCT04871269The Effect of Dronabinol on the Acquisition and Consolidation of Trauma-Associated MemoriesNot applicableActive, not recruitingGermany
NCT07395206Acceptability, Feasibility and Preliminary Outcomes of the Kiso Mind App for Outpatients With Schizophrenia S…Not applicableRecruitingGermany
NCT07769320AngioVac Aspiration Therapy RegistryNot applicableNot yet recruitingGermany
NCT04730518Yoga-based Group Intervention (YoGI) for In-patients With Schizophrenia Spectrum DisordersNot applicableRecruitingGermany
NCT06748027Guidelines on Long-term Medical FastingNot applicableRecruitingGermany
NCT04732910Modulate-CF: Cystic Fibrosis Transmembrane Regulator (CFTR) Biomarker Study to Evaluate the Rescue of Mutant…Not applicableRecruitingGermany
NCT06566066Register for Patients With Thyroid Hormone Resistance.Not applicableRecruitingGermany
NCT05809856Feasibility Study to Evaluate the Safety of the Autologous GrOwnValve Transcatheter Pulmonary Heart ValveNot applicableRecruitingGermany

All sponsors: clinical-trial pipeline by sponsor.

Track a sponsor's pipeline

The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.

Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.

Cite as: Arcadium Data, "Charite University, Berlin, Germany clinical trials: 102 open, 58 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/charite-university-berlin-germany/, data as of 2026-10-25.